Department of Obstetrics and Gynaecology, Tianjin Medical University General Hospital, Tianjin 300052, China.
J BUON. 2021 Mar-Apr;26(2):644.
The Editors of JBUON issue an Expression of Concern to 'Bismahanine exerts anticancer effects on human cervical cancer cells by inhibition of growth, migration and invasion via suppression of NF-kB signalling pathway', by Limin Yu, Yan Sun, Jing Su, Xiang Li, JBUON 2020;25(1):93-98; PMID: 32277619. Following the publication of the above article, readers drew to our attention that part of the data was possibly unreliable. We sent emails to the authors with a request to provide the raw data to prove the originality, but received no reply. Therefore, as we continue to work through the issues raised, we advise readers to interpret the information presented in the article with due caution. We thank the readers for bringing this matter to our attention. We apologize for any inconvenience it may cause.
JBUON 杂志编辑对“Bismahanine 通过抑制 NF-κB 信号通路抑制生长、迁移和侵袭对人宫颈癌细胞发挥抗癌作用”一文表示关注，作者为 Limin Yu、Yan Sun、Jing Su 和 Xiang Li，发表于 JBUON 2020;25(1):93-98; PMID: 32277619。文章发表后，读者提请我们注意，部分数据可能不可靠。我们向作者发送电子邮件，要求他们提供原始数据以证明其原创性，但未收到回复。因此，在我们继续处理提出的问题时，我们建议读者谨慎解读该文章中的信息。感谢读者对此事的关注。对于由此造成的任何不便，我们深表歉意。
